Penserra Capital Management LLC Aprea Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

$4.61 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 15, 2022	SELL	$2.87 - $5.58 $1,406 - $2,734	-490 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.43 - $5.63 $34 - $56	10 Added 2.08%	490 $2,000
Q2 2021 Aug 12, 2021	BUY	$4.05 - $5.5 $20 - $27	5 Added 1.05%	480 $2,000
Q1 2021 May 13, 2021	SELL	$4.73 - $8.15 $47 - $81	-10 Reduced 2.06%	475 $2,000
Q4 2020 Feb 12, 2021	BUY	$4.92 - $30.67 $2,386 - $14,874	485 New	485 $2,000

Others Institutions Holding APRE

# of Institutions

2

Shares Held

899

Call Options Held

0

Put Options Held

0

Nbc Securities, Inc. Birmingham, AL

899
Shares

$2,885
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.